Pathological Complete Response in Stage IV Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer With Synchronous Liver Metastases After Conversion Therapy With SOX Plus Cadonilimab and Disitamab Vedotin
Gastroenterology Research · 2026-10 · 19 (5) · 295-301
DOI: 10.14740/gr2193 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastroenterology Research, 2026-10. Verfasst von Xin Shi und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Shi, X., Wang, W. J., He, K. J., Wang, D. C., Li, X. Q., & Xu, L. (2026). Pathological Complete Response in Stage IV Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer With Synchronous Liver Metastases After Conversion Therapy With SOX Plus Cadonilimab and Disitamab Vedotin. Gastroenterology Research, 19(5), 295-301. https://doi.org/10.14740/gr2193
Vancouver
Shi X, Wang WJ, He KJ, Wang DC, Li XQ, Xu L. Pathological Complete Response in Stage IV Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer With Synchronous Liver Metastases After Conversion Therapy With SOX Plus Cadonilimab and Disitamab Vedotin. Gastroenterology Research. 2026;19(5):295-301. doi:10.14740/gr2193
BibTeX
@article{Shi2026,
author = {Shi, Xin and Wang, Wei Jun and He, Ke Ji and Wang, De Chen and Li, Xiao Qin and Xu, Li},
title = {Pathological Complete Response in Stage IV Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer With Synchronous Liver Metastases After Conversion Therapy With SOX Plus Cadonilimab and Disitamab Vedotin},
journal = {Gastroenterology Research},
year = {2026},
volume = {19},
number = {5},
pages = {295--301},
doi = {10.14740/gr2193}
}
EUVIMED